This Disease Hikes Health Care Costs By More than $10,000 a Year
Medical professionals and economists have been worried about the growing prevalence of diabetes for years. A new report shows their concerns are well placed. In 2013, the per capita health care bills of consumers with diabetes was $15,000, nearly 71 percent ($10,700) higher than those without the disease, according to the Healthcare Cost Institute.
The brunt of those bills are borne by health care providers, but consumers with diabetes have per capita out-of-pocket costs of $1,922, compared to just $738 for those who do not have diabetes.
For those under the age of 65, health care expenses grew an average 4.1 percent from 2012 to 2013, but the increase was even higher among children, who saw expenses rise 7 percent from 2011 to 2012 and then another 9.6 percent from 2012 to 2013.
Related: Diabetes Detection Up in Pro-Obamacare States
“There has been extraordinary growth in health spending for children with diabetes,” HCCI senior research Amanda Frost said in a statement, citing branded insulin as one factor in the increase.
For children, the costs go beyond medication. A 2012 study in Health Affairs found that people who develop diabetes before age 30 make less money than their peers, are more likely to drop out of high school and less likely to attend college.
One of the most widespread chronic diseases in the United States, diabetes care consumes about 10 percent of U.S. health care spending, according to a study by the University of Michigan.
Chart of the Day: Boosting Corporate Tax Revenues
The leading candidates for the Democratic presidential nomination have all proposed increasing taxes on corporations, including raising income tax rates to levels ranging from 25% to 35%, up from the current 21% imposed by the Republican tax cuts in 2017. With Bernie Sanders leading the way at $3.9 trillion, here’s how much revenue the higher proposed corporate taxes, along with additional proposed surtaxes and reduced tax breaks, would generate over a decade, according to calculations by the right-leaning Tax Foundation, highlighted Wednesday by Bloomberg News.
Chart of the Day: Discretionary Spending Droops
The federal government’s total non-defense discretionary spending – which covers everything from education and national parks to veterans’ medical care and low-income housing assistance – equals 3.2% of GDP in 2020, near historic lows going back to 1962, according to an analysis this week from the Center on Budget and Policy Priorities.
Chart of the Week: Trump Adds $4.7 Trillion in Debt
The Committee for a Responsible Federal Budget estimated this week that President Trump has now signed legislation that will add a total of $4.7 trillion to the national debt between 2017 and 2029. Tax cuts and spending increases account for similar portions of the projected increase, though if the individual tax cuts in the 2017 Republican overhaul are extended beyond their current expiration date at the end of 2025, they would add another $1 trillion in debt through 2029.
Chart of the Day: The Long Decline in Interest Rates
Are interest rates destined to move higher, increasing the cost of private and public debt? While many experts believe that higher rates are all but inevitable, historian Paul Schmelzing argues that today’s low-interest environment is consistent with a long-term trend stretching back 600 years.
The chart “shows a clear historical downtrend, with rates falling about 1% every 60 years to near zero today,” says Bloomberg’s Aaron Brown. “Rates do tend to revert to a mean, but that mean seems to be declining.”
Chart of the Day: Drug Price Plans Compared
Lawmakers are considering three separate bills that are intended to reduce the cost of prescription drugs. Here’s an overview of the proposals, from a series of charts produced by the Kaiser Family Foundation this week. An interesting detail highlighted in another chart: 88% of voters – including 92% of Democrats and 85% of Republicans – want to give the government the power to negotiate prices with drug companies.